top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


Do The Mutations That Drive Cancer Actually Affect Immunity?
A study in the journal Oncogene finds that pancreatic cancer may progress as a result of the loss of normal immune response. (source: ...

Dr. Robert A. Nagourney, MD
Sep 20, 20222 min read


IN HER2 (+) BREAST CANCER, THE MOST WIDELY USED TREATMENT MAY NOT BE THE RIGHT ONE FOR YOU
Despite advances in breast cancer management, we must all recognize that every patient is unique and their treatments should be too.

Dr. Robert A. Nagourney, MD
Aug 30, 20222 min read


STAGE IV PANCREATIC CANCER: A GOOD OPTION AFTER FOLFIRINOX?
40-year-old Hispanic female transferred from UCSD after presenting several weeks earlier with widely metastatic Stage IV pancreatic cancer.

Dr. Robert A. Nagourney, MD
Aug 16, 20223 min read


Stage 4 Triple-Negative Breast Cancer: The Right Treatment May Be At Hand.
A famous medical center recommended a treatment widely used for breast cancer, but not necessarily the best one for Stage 4 Triple-Negative.

Dr. Robert A. Nagourney, MD
Aug 11, 20223 min read


Chemosensitivity Testing Must Evolve at All Medical Providers
Today, patients with newly diagnosed or recurrent cancer are offered chemotherapy. Drugs are administered where possible for cure but far...

Dr. Robert A. Nagourney, MD
Aug 9, 20222 min read


WHEN THERE’S NO RIGHT ANSWER THERE ARE MANY WRONG ANSWERS
Selecting cancer treatment can be challenging and patients with recurrent diseases are particularly challenging. One patient with...

Dr. Robert A. Nagourney, MD
Jul 13, 20222 min read


DNA Signatures and Genomics
Cancer patients have seen enough interesting science. They want answers and at our laboratory, we give them answers that matter

Dr. Robert A. Nagourney, MD
Jul 7, 20222 min read


BREAKTHROUGH IN RECTAL CANCER: ADVANCING IMMUNE THERAPY
With a 100% response rate in 12 of 12 patients, the PR value was off the charts but what did theses investigators really show?

Dr. Robert A. Nagourney, MD
Jun 29, 20223 min read


PROGRESS IN CHILDHOOD SARCOMA – HIGH-DOSE IFOSFAMIDE
An ASCO Plenary Session reported that high-dose ifosfamide was superior to the combination of cyclophosphamide plus topotecan in Ewing...

Dr. Robert A. Nagourney, MD
Jun 8, 20221 min read


NEW STAGE 4 COLON CANCER DATA
Investigators from Japan reported at the American Society for Clinical Oncology that patients with left-sided colon cancer have a better...

Dr. Robert A. Nagourney, MD
Jun 8, 20221 min read


JUST BECAUSE A DRUG WORKS DOESN’T MEAN THEY’LL PAY FOR IT
Health insurance doesn't care about getting you the right treatment to beat your cancer!

Dr. Robert A. Nagourney, MD
Apr 25, 20222 min read


IS 8% OF THE GENOME THE MISSING LINK FOR ADVANCED CANCER?
In the modern era, discoveries in human genomics get front-page coverage. Following the 2003 publication of the human genome made up of...

Dr. Robert A. Nagourney, MD
Apr 4, 20222 min read


STAGE 4 PANCREATIC CANCER - DOING MORE WITH LESS
There were 60,430 new diagnoses and 48,220 deaths from pancreatic cancer in 2021. With a 5-year survival of 3% for advanced disease,...

Dr. Robert A. Nagourney, MD
Mar 21, 20222 min read


Let's Talk About “CHEMOTHERAPY”
Raymond Carver’s 1981 collection of short stories, “What We Talk About When We Talk About Love” was featured in the 2014 movie, Birdman....

Dr. Robert A. Nagourney, MD
Feb 24, 20222 min read


STAGE 4 PANCREATIC CANCER: WHEN SCIENCE FAILS THE PATIENT
Pancreatic cancer is among the most lethal of all human malignancies, with 60,430 new diagnoses and 48,220 deaths in 2021, it is the 3rd...

Dr. Robert A. Nagourney, MD
Jan 25, 20223 min read


A NEW TARGET, A NEW DRUG AND A CHILD IN NEED
The problem: Larotrectinib had never been used in South America and was not approved in Brazil.

Dr. Robert A. Nagourney, MD
Nov 16, 20213 min read


IS STAGE 4 METASTATIC PANCREATIC CANCER CURABLE?
Few cancers strike greater fear into patients than pancreatic cancer. With over 60,000 new cases per year and 48,000 deaths, this disease...

Dr. Robert A. Nagourney, MD
Oct 18, 20213 min read


NOTHING NEW UNDER THE SUN: PERSPECTIVES ON OVARIAN CANCER
I gave a Ted Talk entitled "The Future of Cancer Research Lies Behind Us." I was commenting on the fact that many new things are...

Dr. Robert A. Nagourney, MD
Sep 20, 20214 min read


SEVEN WITH ONE BLOW: OVERCOMING THE ODDS IN CANCER
Those who have read my blogs know that I apply the EVA/PCD laboratory method to
select treatments and combinations. This grants me a higher

Dr. Robert A. Nagourney, MD
Apr 12, 20214 min read


IN ADVANCED CANCER, QUALITY NOT JUST QUANTITY OF LIFE MATTERS
With the explosion of new cancer drugs, combinations, targeted agents, and immune therapies, one question remains: What is the impact of...

Dr. Robert A. Nagourney, MD
Feb 24, 20213 min read
bottom of page